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Respiratory viral infections trigger a robust inflam-
matory response in the lung, producing cytokines,
chemokines, and growth factors that promote infil-
tration of effector leukocytes. Whereas the role of
chemokines and infiltrating leukocytes in antiviral
immunity is well studied, the effect that lung cyto-
kines have on leukocytes in distal hematopoietic
and lymphoid tissues and their role in antiviral immu-
nity is unknown. We show that, during infection with
influenza or Sendai virus, the lung communicates
with the sterile bone marrow, the primary site of
hematopoiesis, through type I interferons. While in
the bone marrow, leukocytes exposed to type I inter-
ferons activate an antiviral transcriptional program
and become resistant to infection with different
viruses. The protected bone marrow leukocytes are
capable of migrating to the infected lung and
contribute to virus clearance. These findings show
that appropriate instruction of cells during their
development in the bone marrow is needed for effec-
tive control of infection.
INTRODUCTION
Infections with viruses that replicate in the respiratory tract
trigger a robust inflammation in the lung. The inflamed lung
produces cytokines, chemokines, and growth factors that
promote a massive infiltration of cells. This infiltrate is composed
by a large number of granulocytes, monocytes (Aldridge et al.,
2009; Lin et al., 2008), natural killer cells (NK) (Gazit et al.,
2006), plasmacytoid dendritic cells (pDCs), conventional DCs
(cDCs) (Grayson et al., 2007; Wolf et al., 2009), and other cell
types that are critical for the clearance of the infection and for
the initiation of adaptive immunity (GeurtsvanKessel et al.,
2008; Kim and Braciale, 2009; Moltedo et al., 2009). Much
work has been performed to identify the chemokines that act
to promote lung leukocyte infiltration during infection, to
subclassify these cells, and to study their role during antiviral
immunity. However, the effect that the lung cytokine milieu has
on leukocytes in distal hematopoietic and lymphoid organs has
been overlooked, and whether such effect has implications in
immunity to virus infection is unknown.CellAmong the cytokines produced in the infected lung are the type
I interferons (IFNs), which have been extensively studied due
to their potent antiviral properties. Type I IFNs are produced by
infectedepithelial cells (Jewell et al., 2007), pDCs, alveolarmacro-
phages, and other cells (Kumagai et al., 2007). Binding of type I
IFNs to their receptor induces the transcription of a number of
IFN-stimulated genes (ISGs), establishing an antiviral state
(Samuel, 2001). ISGs include genes coding for sensors of viral
RNAsuchas the retinoic acid induciblegene (RIGI) andmelanoma
differentiation-associated gene5 (MDA5), signaling proteins such
as the interferon regulatory factor7 (IRF7), andproteins involved in
general resistance to viral infection such as myxovirus resistance
1 (Mx1) and ISG15. The importance of type I IFNs as amajor anti-
viral mechanism is evident, as virtually all pathogenic viruses
encode for antagonists of type I IFN production and/or function
(Randall and Goodbourn, 2008; Weber et al., 2004). In addition,
type I IFNs affect the development of the immune response by
promoting DC maturation (Luft et al., 1998), NK cell activation
(Biron et al., 1999), CD4+ Th1 bias (Murphy et al., 2000), and
antigen-specific T cell proliferation (Kolumam et al., 2005).
Studies conducted in vitro have shown that treatment of
leukocytes such as monocytes (Gerlini et al., 2008) and mono-
cyte-derived DCs (Osterlund et al., 2005; Phipps-Yonas et al.,
2008) with type I IFNs prior to virus infection limits the ability of
the virus to replicate in these cells while improving their ability
to stimulate T cells (Gerlini et al., 2008). We hypothesized that
leukocyte priming by type I IFNs also occurs in vivo and that
leukocytes educated in the periphery by type I IFN signaling
are recruited to the lung during infection to improve the efficiency
of virus clearance.
The bonemarrow (BM) is themajor site of hematopoiesis in the
adult. In the steady state, millions of leukocytes, erythrocytes,
and hematopoietic stem cells (HSCs) are released daily from
the BM in order to replenish the hematopoietic compartment
throughout the organism. Inflammation in any organ of the
body significantly changes the environment and cell composition
of the BM, leading to the release of monocytes (Serbina and
Pamer, 2006; Tsou et al., 2007), neutrophils (Navarini et al.,
2009; Wengner et al., 2008), NK cells (Bernardini et al., 2008),
and HSCs (Nardini et al., 2005; Zhang et al., 2008) to the blood.
The BM is, therefore, the most likely main supplier of cells to
inflamed tissues. Studies using noninfectious inflammatory
models, bacterial infections, or models of systemic infection
have helped to elucidate some of the events occurring in the
BM during inflammation. However, very limited research has
been done with regard to the events occurring in the BM during
a distal viral infection, and the function of released BMcells in the
resolution of a respiratory infection has not been investigated.Host & Microbe 7, 343–353, May 20, 2010 ª2010 Elsevier Inc. 343
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Cell Host & Microbe
Bone Marrow Response to Lung Virus InfectionInfection with Sendai virus (SeV) or with most strains of
influenza virus in mice does not lead to viremia because these
viruses replicate exclusively in the respiratory tract (Scheid and
Choppin, 1974; Tashiro et al., 1992).We chose SeV and influenza
virus to study the systemic effect of cytokines produced in the
lung during infection without the complicating contribution of
direct viral infection of cells outside of the respiratory tract.
Here, we demonstrate that infection of the lung is sensed
systemically and that cells in distal organs, including the BM,
are instructed to generate an improved response to the path-
ogen when they are recruited to the infection site. Overall, our
findings suggest that the communication between the infected
lung and leukocytes developing in the BM is an integral part of
the immune response to respiratory virus infections. This previ-
ously underappreciated mechanism may provide useful insight
for the development of medical strategies for the treatment of
lethal virus infections and other immune disorders that involve
BM leukocytes.
RESULTS
SeV Infection Induces a Systemic Antiviral Response
To characterize the inflammatory response induced by SeV
infection, we quantified the levels of multiple cytokines and
chemokines in the lung and blood of mice at different times
postinfection (Figures 1Aand1B). Similar to the kinetics of inflam-
mation reported for influenza virus infection (Moltedoet al., 2009),
cytokines and chemokines began to be detected in the lung on
the second day after infection, reaching high levels at days
3–5 postinfection. The same kinetics was closely followed in
the blood (Figure 1B). Though type I IFNs (IFNa and IFNb) were
detected in the lung,wewere not able to detect them in the serum
using conventional ELISA. As expected, the induction of chemo-
kines in the infected respiratory tract correlated with a robust
infiltration of leukocytes into the lung (Figure 1C).
We then assessed the expression of antiviral genes in lung,
spleen, BM, and peripheral lymph nodes (pLNs) of infected
animals. Transcription of ISG15, IRF7, Mx1, RIGI, and MDA5
was observed in all of the organs tested (Figure 1D and data
not shown) following the same kinetics as the lung inflammatory
response (Figure 1A). The enhanced antiviral gene expression
observed in the BM was not due to a relative increase in the
pDC population that constitutively expresses IRF7 (Izaguirre
et al., 2003) (Figure S1 available online).
Lung-Derived Type I IFNs Trigger the BM Antiviral
Response
Because the genes induced in the periphery are known targets of
type I IFN signaling, we investigated whether these cytokinesFigure 1. Lung Inflammation Correlates with the Systemic Transcriptio
(A and B) Cytokines from (A) fresh lung homogenates and (B) sera obtained from
(M)-infected animals were used as controls.
(C) Lung cell count after tissue digestion. Cell numbers for specific cell populatio
live (PI) CD45+ cells. B cells (CD11bmPDCAB220+), pDCs (CD11bmPDCA
(NK1.1+CD11b+), cDCs (CD11c+MHCII+CD11b+), CD4+ T cells (CD3+CD4+CD8
(D) ISG15 and IRF7 mRNA levels in the lung, pLNs, BM, and spleen at different da
a-tubulin, rps11, and b-actin of each sample analyzed.
Error bars represent SD of triplicate measurements in a representative experime
Cellwere responsible for the induction of antiviral genes in the BM.
We infected type I IFN receptor-deficient (IFNRKO) mice with
SeV or influenza virus and compared their gene expression in
the BM to that of WT controls. Infected IFNRKO mice exhibited
impaired induction of antiviral genes compared to controls
(Figures 2A and 2B). The inflammatory cytokines IL12p70, IL6,
IFNb, and IFNg were produced to high levels in the lungs of
SeV-infected IFNRKO mice, demonstrating that the impairment
observed in the BM of these mice was not due to reduced
cytokine production in the lung (Figure 2C). In addition, in
chimeric mice, WT donor hematopoietic cells upregulated the
transcription of antiviral genes in response to SeV infection,
whereas donor IFNRKO hematopoietic cells did not, regardless
of the host responsiveness to type I IFN (Figure 2D). These
results indicate that type I IFNs provide the primary signal for
the induction of antiviral genes in BM cells.
To more closely examine the source of the type I IFNs that
activate the BM during infection, we measured the level of
IFN a and b mRNAs in the lung, spleen, pLNs, blood, and BM
cells isolated from mice infected with SeV (Figures 2E and
S2A). Transcription of type I IFNs was only detected in the lung
of infected mice. In addition, we were unable to detect expres-
sion of IFNs or any other cytokines (IL28a, IFNg, CCL2, IL-6,
and G-CSF) in any discrete BM cell population (Figure S2B and
data not shown), indicating that the source of IFNs activating
the BM is solely the site of infection.
We then hypothesized that, during infection, type I IFNs were
transported through the blood to peripheral organs at levels
undetectable by commercially available ELISAs. To examine
whether type I IFNs were present in the serum, we used a sensi-
tive bioassay. In this assay, serum obtained at different times
after infection with SeV was incubated ex vivo with BM cells
isolated from noninfected mice. The expression of antiviral
genes by the BM cells was then determined by qRT-PCR. BM
cells isolated from uninfected mice and incubated with serum
isolated from infected mice showed increased antiviral mRNA
transcripts (Figure 2F), similar to what we had observed in vivo.
However, IFNRKO BM cells incubated with the same serum
were unresponsive, indicating that type I IFNs present in the
blood of infected mice were at least partially responsible for
the observed gene expression. Altogether, these results show
that type I IFNs originated in the infected lung are distributed
systemically through the blood and instruct cells in the BM to
confront the infection.Induction of Antiviral Programming of the BM Does
Not Result from Direct Virus Infection
We next confirmed that, in our system, virus replication was
restricted to the lung. Viral nuclear protein (NP) mRNA wasn of Antiviral Genes
mice infected with SeV and sacrificed at different days postinoculation. Mock
n were extrapolated from flow cytometry analysis. The cells were pregated on
+B220+), monocytes (Ly6c+Ly6gCD115+), granulocytes (Ly6c+Ly6g+), NKs
), and CD8+ T cells (CD3+CD4-CD8+).
ys after infection with SeV. mRNA was normalized to the housekeeping genes
nt. See also Figure S1.
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Figure 2. Transcription of Antiviral Genes in the BM Is Induced by Type I IFNs Transported in the Blood
(A and B) Gene expression in BMof wild-typemice or type I IFN receptor KOmice infected with (A) SeV 2 days after infection or (B) influenza PR8 virus 3 days after
infection.
(C) Cytokines in lung homogenates obtained from WT and IFNRKO mice 3 days postinfection.
(D) Gene expression in the BM of complete chimeric mice infected for 5 days with SeV (n = 4 mice in each group; *p < 0.05). (E) IFNb expression in the lung, BM,
blood, peripheral lymph nodes (pLN), and spleen of wild-type mice infected with SeV. See also Figure S2.
(F) Gene expression in naive BM cells isolated fromWT (top) or IFNRKO (bottom) mice after a 6 hr incubation with serum obtained fromwild-type mice at different
times after infection with SeV. n = 3 mice in each group; *p < 0.05.
Error bars represent mean ± SD.
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Table 1. Virus Titers upon Infection with SeV and Influenza Virus
WT IFNRKO
Viral NPa Virus Titerb Viral NP Virus Titer
SeV Lung 5557 ± 36 5 ± 0.36 16,003 ± 265* 5.7 ± 0*
BM ND ND ND NM
Blood ND ND ND NM
Influenza Lung 3035 ± 59 5.7 ± 0 3401 ± 68 NM
BM ND NM ND NM
Blood ND NM ND NM
ND, not detected; NM, not measured; *p > 0.05 compared to WT.
a Viral NP was measured on day 4 postinfection by qRT-PCR. Expressed
as relative copy numbers. n = 3.
b Viral titers in the lung measured on day 4 postinfection. BM and blood
titers measured on day 5 postinfection. Expressed as log TCID50/25ul
lung. n = 4.
Cell Host & Microbe
Bone Marrow Response to Lung Virus Infectiondetected at high levels in the lungs of mice infected with either
SeV or influenza virus but was not detected in their blood or
BM (Table 1). Furthermore, we did not detect replicating SeV in
the BMand blood of infectedmice at any time analyzed, whereas
infectious virus was found at high titers in the lung (Table 1 and
data not shown). In addition, the expression of viral proteins
and virus replication were significantly higher in the lungs of
IFNRKO mice than in those of WT mice. Despite the higher level
of virus in IFNRKO lung, viral mRNA was not detected in the BM
of these mice, confirming that SeV and influenza virus do not
replicate in the blood or BM of infected animals. These results
validate the use of these viruses to study the effects of a localized
virus infection that does not reach the BM compartment.
BM Cells from Infected Mice Are Protected
from Viral Replication
We reasoned that the expression of antiviral genes confers
protection to leukocytes against virus infection while in the BM
or when recruited to the infected lung. We therefore investigated
whether BM cells isolated from infected mice were resistant to
virus infection. To do so, BM cells isolated at different times after
infection with SeV (Figure 3A) or influenza virus strain X-31
(Figure 3B) were infected ex vivo with SeV, influenza PR8 virus,
or herpes simplex virus (HSV) and viral replication was deter-
mined through the expression of viral mRNA. BM cells isolated
from infected mice resisted infection by all three viruses. These
results indicate that leukocytes in the BM of infected mice are
programmed to limit virus replication.
B Cells, pDCs, and Monocytes in the BM Are Instructed
by Type I IFN to Confront a Viral Infection
To determine which leukocytes in the BM responded to type I
IFNs produced in the infected lung, we performed flow
cytometry analysis on cells obtained from the BM of Mx-Cre 3
Rosa26-stopfloxEGFP reporter mice. The activation of the type
I IFN-sensitive Mx promoter in these mice leads to the expres-
sion of Cre recombinase that removes a stop cassette upstream
of the floxed reporter, leading to EGFP expression (Ku¨hn et al.,
1995; Mao et al., 2001). In these reporter mice, cells that are
activated by type I IFN express EGFP permanently. BM pDCs,
B cells, and monocytes isolated from infected mice showedCellincreased expression of EGFP compared to mock-infected or
Rosa26-EGFP littermates that do not express Mx-Cre (Fig-
ure 4A). Sorted cells from the BM of infected mice demonstrated
an enhanced transcription of antiviral genes compared to control
mice, demonstrating that these cells were instructed while
residing in the BM (Figures 4B and S2B).
Monocytes recruited from the BM have been proposed to
contribute to immunity against respiratory viruses (Aldridge
et al., 2009; Lin et al., 2008). In our system, BM monocytes from
infected mice that were infected ex vivo were less permissive to
both SeV and influenza virus replication than monocytes from
control animals (Figure 4C), similarly to total BM cells (Figure 3).
To determine the role of these cells during the resolution of SeV
infection, we infected CCR2-deficient (CCR2KO) mice that
show impaired recruitment of monocytes in other infection
models (Aldridge et al., 2009; Lin et al., 2008; Navarini et al.,
2009; Serbina and Pamer, 2006; Tsou et al., 2007). As
expected, CCR2KO mice had a reduced number of monocytes
in the blood compared toWTmice. These animals also exhibited
impaired recruitment of monocytes to the lung during the course
of SeV infection while these cells accumulated in the BM (Figures
S3A, S3B, and S3C). In addition, CCR2KOmice showed delayed
clearance of SeV as compared to WT controls (Figure 4D), sug-
gesting that monocytes recruited from the BM and instructed
during infection play a role in the clearance of SeV from the
lung. The failure to promptly clear the virus from CCR2KO mice
was independent of recruitment of T cells to the lung, as similar
numbers of CD8+ virus-specific T cells were present in the lung
at various time points after infection (Figure S3D).
Type I IFN Priming of Cells Newly Recruited
to the Lung Is Needed for Rapid Viral Clearance
We examined whether exposure of BM cells to type I IFN
affected their function upon recruitment to the lung during infec-
tion. To do this, we determined the extent of viral replication and
cytokine transcription in hematopoietic cells (CD45+) purified
from the infected lung of BM transplant recipients. IFNRKO
CD45+ cells showed higher levels of both SeV NP and F mRNA
than WT CD45+ cells, regardless of the host’s IFN responsive-
ness (Figure 5A). However, despite exhibiting a lower level of viral
mRNA, WT donors showed higher transcription levels of the
proinflammatory genes IL12p40, CCL2, and CXCL10. SeV titers
of whole-lung homogenates corroborated the essential role of
hematopoietic cells primed by type I IFN in controlling virus
replication in vivo (Figure 5B).
Of note, in type I IFN receptor-deficient mice, whole-lung
homogenates showed enhanced cytokine production compared
toWTmice (Figure 2C), differently than the response observed in
pure hematopoietic cell preparations (Figure 5A). It is possible
that the contribution of different lung cell types to the cytokine
response is altered in the absence of type I IFN. To rule out the
possibility that the differences between WT and IFNRKO cells
recruited to the lung were due to the different virus burden and
cytokine environment that these cells were exposed to in the
lung, we generated mixed chimeric mice transplanted with a
1:1 ratio ofWT and IFNRKOdonor BMcells in aWT host. In these
animals, both WT and IFNRKO cells were exposed to the same
environment. Analysis of gene expression in cells sorted from
the lungs of infected mixed chimeras (Figure 5C) confirmedHost & Microbe 7, 343–353, May 20, 2010 ª2010 Elsevier Inc. 347
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Figure 3. BM Cells of Mice Undergoing
a Respiratory Infection Are Protected from
Viral Replication
(A and B) Expression of viral genes in BM cells
isolated at different days after infection with (A)
SeV or (B) influenza virus strain X31 after 6 hr of
infection ex vivo with SeV, influenza strain PR8, or
HSV at an MOI of 2. n = 4 mice in each group.
Error bars represent mean ± SD.
Cell Host & Microbe
Bone Marrow Response to Lung Virus Infectionthat responsiveness to type I IFN protects hematopoietic cells
from infection in the lung and allows for their maximal contribu-
tion to the inflammatory process through the production of
proinflammatory molecules.
BM Leukocytes from Infected Mice Are Recruited
to the Lung and Are Protected from Virus Infection
To determine whether BM leukocytes are recruited to the lung
during infection, we followed the migration of adoptively trans-
ferred BM leukocytes in an infected animal. To do this, we
isolated BM cells from CD45.1+WT or IFNRKOmice 4 days after
infection with SeV (Figure S4). The cells were labeled with high
and low levels of carboxyfluorescein diacetate succinimidyl ester
(CFSE), respectively, andwere adoptively transferred toCD45.2+
WT mice that had been infected for 2 days with SeV (Figure 6A).
This timing was selected to ensure that the appropriate cytokine
and chemokine environment had been established in the lung of
host mice and that newly recruited cells had not yet saturated the
lung. One day after the adoptive transfer, CD45.1+ cells from the
lung and spleen of recipient mice were enriched and sorted
based on their CFSE content. A slightly higher proportion of WT
than IFNRKO donor cells was found in the infected host lung
(Figure 6B). Most of the cells of either type found in the lung
wereofmyeloid origin, as indicatedby their expression ofCD11b.
Adoptively transferred BM cells that infiltrated the lungs, but
not the spleen, expressed viral mRNA (Figure 6C), supporting
the evidence that replication of SeV was restricted to the lung.
Similarly to what we observed in chimeric animals (Figure 5),
the level of virus replication was higher in IFNRKO cells present
in the lung compared with WT cells. In addition, transferred
IFNRKO BM cells demonstrated impaired production of type I348 Cell Host & Microbe 7, 343–353, May 20, 2010 ª2010 Elsevier Inc.IFNs and other cytokines in the lung of
host animals compared with WT trans-
ferred cells (Figure 6D). Cytokine induction
was only observed in the cells infiltrating
the lung, demonstrating that, although
the cells are primed in the BM, they will
only produce cytokines once they sense
the virus in the lung. These data show
that leukocytes primed in the BM can
infiltrate the infected lung and become
efficient cytokine producers while pro-
tected from virus infection.
DISCUSSION
A number of different cell types are
engaged in combating the pathogen inthe lung during the days that immediately follow infection, prior
to the activation of the adaptive immune response (Kohlmeier
andWoodland, 2009). Because the BM is themajor site of hema-
topoiesis in the adult mammal (Kondo et al., 2003), it is likely
to contribute to replenishing and supplying most of the cells
recruited to the lung during infection.
Infections with different viruses, including human immunodefi-
ciency virus (Alexaki and Wigdahl, 2008; Prost et al., 2008),
vaccinia virus (Singh et al., 2008), lymphocytic choriomeningitis
virus (Binder et al., 1997), murine cytomegalovirus (Crane et al.,
2009), and bacterial infections, have a documented effect on the
BM (Feng et al., 2008; Navarini et al., 2009; Serbina and Pamer,
2006; Tsou et al., 2007; Ueda et al., 2005). In addition, treatment
of mice with Toll-like receptor agonists was shown to drive differ-
entiationof hematopoietic stemcells in theBMtowardmonocytes
or DCs (Nagai et al., 2006; Welner et al., 2008). These models
illustrate the ability of cells in the BM to respond to a systemic
stimulus. However, the immune response to an infectious agent
is tremendously complex. These studies do not discriminate
between the direct detection of the pathogen that can breach
the site of infection and the sensing of the proinflammatory envi-
ronment derived from the primary infection site. SeV and most
strains of influenza virus do not disseminate from the respiratory
tract to theblood or other peripheral organs. Thesemodels permit
the study of the BM responsiveness to the systemic inflammatory
signals, which originates in the infected lung without the compli-
cating effect of direct viral infection of the cells in the BM.
Based on recent studies pointing out the responsiveness of
dormant HSCs to type I IFNs (Essers et al., 2009; Sato et al.,
2009), it is reasonable to hypothesize that, due to the cytokine
storm that follows infection with SeV and influenza virus, HSC
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Figure 4. Monocytes Primed in the BM
Participate in theControl of Virus Replication
in the Lung
(A) EGFP expression in BM B cells (PISSloB220+
CD11bmPDCA), pDCs (PISSloB220+CD11b
mPDCA+), andmonocytes (PISSloCD115+CD11b+
Ly6c+) from Mx-Cre 3 Rosa26-stopfloxEGFP mice
infected for 3, 5, or 7 days with SeV (tinted), mock-
infected (black dashed line), or Mx-Cre(neg)
Rosa26-stopfloxEGFP litter mates (black line).
(B) Gene expression in BM monocytes (Ly6c+
Ly6gCD115+) sorted from mock- or SeV-infected
mice at day 4 postinfection (n = 6 mice in each
group; *p < 0.05).
(C) Viral gene expression in BMmonocytes isolated
from mice 4 days postinfection with SeV and after
ex vivo infection with either SeV or influenza PR8.
Mock-infected animals were used as controls
(n = 6 mice in each group; *p < 0.05).
(D) SeV titers in lung homogenates of wild-type or
CCR2KO mice after infection with SeV. TCID50,
50% tissue culture infectious dose. n = 3–4 mice
in each group; *p < 0.05.
Error bars representmean±SD. See also Figure S3.
Cell Host & Microbe
Bone Marrow Response to Lung Virus Infectionactivity in the BM is also influenced, leading to the differentiation
and release of cells specifically prepared to resist and fight infec-
tion. Of interest, we were unable to detect transcripts of IL6,
IL12p40, CCL2, and type I IFNs (or other cytokines mRNA) in
leukocytes from the BM of infected mice at any time postinfec-
tion. Restricted cytokine production in the infected organ may
avoid the risk of overwhelming the BM compartment with cyto-
kines that will either overdrive cell proliferation or cause cell
death, leading to BM exhaustion.
The rate-limiting step for antiviral induction in the BM appears
tobe theproduction of inflammatory cytokines at the site of infec-
tion (Moltedo et al., 2009). Though the antiviral activity of type I
IFNs is extensively documented, it is usually considered to signal
over short distances with a short half-life (Peleg-Shulman et al.,
2004; Pepinsky et al., 2001). We have demonstrated that, during
a respiratory infection, type I IFNs signal over long distances and
that type I IFNs present in the serum are sufficient to instruct cells
in the BM. Our data do not eliminate the possibility that other
mechanisms exist for the transport of type I IFN to the BM during
infection. Of note, wewere unable to detect transcription of type I
IFNs in theBM, spleen, pLNs, thymus, or blood at any timebefore
or after infection. Although it has been suggested that type I IFNs
are continually produced in the steady state (Lienenklaus et al.,
2009; Wang et al., 1995), our results show that induction of anti-
viral genes in noninfected tissues occurs only after type I IFNs are
produced at the site of infection.
It has been reported that BM B cells are reduced during
influenza infection, suggesting that cells residing in the BM
respond to the lung inflammation (Sedger et al., 2002). Our
data demonstrate that acute infection of the lung is sensed,
mainly through type I IFN signaling, by different cells in the BM.Cell Host & Microbe 7, 343–This signal educates BM cells for their
future encounter with viral cues, making
them resistant to virus infection and
hyperresponsive to viral danger signals.These data demonstrate that the reported enhancement of
cytokine production in response to virus infection of DCs and
monocytes previously exposed to type I IFN in vitro also occurs
during the context of infection in vivo (Gerlini et al., 2008; Oster-
lund et al., 2005; Phipps-Yonas et al., 2008). The need for cells
to be recruited from the BM to the lung in order to fight infection
efficiently is highlighted by the delayed clearance of SeV virus
from the lungs of CCR2KO mice in which monocytes do not
efficiently infiltrate the site of infection. It stands to reason that
recruitment of primed cells is even more advantageous than
that of cells that did not acquire the antiviral state. Future studies
will need to address how various cell subtypes respond in the
BM to the inflammatory environment and what are their relative
contributions to virus control.
Viruses that employ a distinct mechanism and strategies for
entry, replication, and antagonism failed to replicate in primed
BM cells, indicating that the antiviral effect observed in the BM
is broad andnot specific to theoriginal infectious agent. Immuno-
suppressed individuals—for example, patients receiving BM
transplants—are extremely prone to viral infections (Styczynski
et al., 2009). These patients are currently treated with specific
antiviral drugs to avoid infectionor reactivation of chronic viruses.
Based on our studies, it is reasonable to propose that priming of
BM cells with low doses of type I IFNs might provide these
patients with protection against unrestrained virus infection.
EXPERIMENTAL PROCEDURES
Mice and Viruses
C57BL/6 (CD45.2+) and B6.SJL (CD45.1+) mice were obtained from
Taconic Farms. IFNRKO mice (C57BL/6 background) were a kind gift from
Dr. C.B. Wilson (Department of Immunology, Washington University) and353, May 20, 2010 ª2010 Elsevier Inc. 349
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Figure 5. Type I IFNs Arm Hematopoietic Cells against Viral Replication In Vivo
(A) Gene expression by CD45+ cells from the lung of complete chimeric WT or IFNRKO mice after 5 days of infection with SeV.
(B) SeV titers in lung homogenates of chimeric mice at different days after infection.
(C) Viral and chemokine gene expression analysis of CD45.2+ (WT) and CD45.1+ (IFNRKO) cells isolated from the lung of mixed chimeric mice 4 days after
infection with SeV.
n = 3 mice in each group; *p < 0.05. Error bars represent mean ± SD.
Cell Host & Microbe
Bone Marrow Response to Lung Virus Infectionwere backcrossed to a B6.SJL (CD45.1+) background. CCR2KO mice were
purchased from Jackson laboratories (Boring et al., 1997). Mx-Cre mice
(Ku¨hn et al., 1995) were crossed to a reporter strain in which the Rosa26
promoter is upstream of a floxed stop cassette and the EGFP gene (Mao
et al., 2001). Both strains were purchased from Jackson laboratories.
Age- and sex-matched animals were used in all experiments. The animals
were bred and housed in pathogen-free conditions, and the experiments
were performed according to institutionally approved protocols. SeV strain
52 and influenza virus strains PR8 and X31 were grown in 10 day embryonated
chicken eggs (SPAFAS; Charles River Laboratories). Eggs’ allantoic fluid was350 Cell Host & Microbe 7, 343–353, May 20, 2010 ª2010 Elsevier Insnap frozen in ethanol-dry ice bath and stored at 80C. HSV (Kos1.1 strain)
was propagated and titrated on Vero 2.2 cells.
Mice Infection and Lung Virus Titration
Anesthetized mice were infected intranasally with 10–20 50% infectious doses
(ID50) of SeV-52 in phosphate-buffered saline (PBS) or by aerosol (Glass-Col
Corp, Model A4212) with an influenza strain PR8 or X31 dilution of 107.9 virus
particles/12 ml PBS for 30 min. For virus titration, the lungs were extracted,
homogenized in PBS-gelatin (0.1%), and frozen in dry ice-ethanol for preser-
vation. The presence of infectious SeV and influenza virus particles wasc.
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Figure 6. Primed BM Leukocytes Are Recruited to the Lung and Are Protected from Infection
(A) Experimental design for adoptive transfer of primed BM leukocytes. CD45.1+ WT or IFNRKO BM cells from mice infected with SeV for 4 days were labeled
with 3.5 mM or 0.5 mM CFSE, respectively, mixed at a 1:1 ratio, and injected into WT CD45.2+ mice infected for 2 days with SeV. See also Figure S4.
(B) Expression of CD11b by CD45.1+ CFSE high and low cells in the lungs of recipient mice.
(C and D) qRT-PCR analysis of (C) viral mRNA and (D) cytokine mRNA in adoptively transferred BM WT and IFNRKO cells isolated from the lung and spleen.
Error bars represent mean ± SD.
Cell Host & Microbe
Bone Marrow Response to Lung Virus Infectionevaluated by infecting LLCMK2 or MDCK cells (respectively) with 1:10
dilutions of the lung homogenates at 37C. After 1 hr of infection, 175 ml of
medium containing 2 mg/ml trypsin was added, and the cells were further
incubated for 72 hr at 37C. A total of 50 ml of medium was then removed
from the plate and tested by hemagglutination of chicken red blood cells
(RBCs) for the presence of virus particles. Viruses at 1:4 dilutions in 0.5%
chicken RBCs were incubated for 30 min at 4C. The hemagglutination of
RBCs indicated the presence of virus particles.
RNA Isolation and qRT-PCR
Lungs, spleen, pLNs, and thymus were harvested at different times after
infection and homogenized in 3 ml TRIzol reagent (Invitrogen) using Gentle-
MACS Dissociator M tubes (Miltenyi). BM from femurs and tibias was flushed
with cold PBS and resuspended in TRIzol. Cells infected in vitro were resus-
pended in 500 ul of TRIzol. RNA was isolated from TRIzol according to theCellmanufacturer’s protocol. Total mRNAwas analyzed by qRT-PCRas previously
described (Yount et al., 2008). See the Supplemental Experimental Procedures
for list of primers.
Flow Cytometry
Lungs were flushed with cold PBS containing 0.5 mM EDTA and were imme-
diately ground and digested with collagenase (Liberase Blendzymes, Roche,
Indianapolis, IN) in RPMI supplemented with 0.5% FCS at 37C for 45 min.
EDTA was added to the samples for resuspension. BM was flushed with
PBS supplemented with 2% FBS using a 25 gauge syringe. RBCs were lysed
with lysis buffer (BD Bioseciences). Single-cell suspensions were incubated
with anti-mouse CD16/32 (BD Biosciences) for 10 min at 4C. The following
antibodies were used in different staining and magnetic cell separation proto-
cols: B220 (RA3-6B2), CD3 (145-2C11), CD19 (1D3), NK1.1 (PK136), CD49b
(DX5), Ter119, CD11b (M1/70), CD11c (HL3), CD45.1 (A20), CD45.2 (104),Host & Microbe 7, 343–353, May 20, 2010 ª2010 Elsevier Inc. 351
Cell Host & Microbe
Bone Marrow Response to Lung Virus InfectionCD115 (AFS98), Ly6C (AL-21),Gr-1 (RB6-8C5) Ly6G (1A8), IA/IE (M5/114.15.2),
and SiglecH (eBio440c) from BD Biosciences or eBioscience. mPDCA-PE
(JF05-1C2.4.1) was obtained from Miltenyi Biotec. Immediately before
reading the samples, propidium iodide (PI) was added to exclude dead cells.
PE-conjugated SeV NP specific tetramer was purchased from Proimmune.
Flow cytometry was performed in a Cytomic FC500 Coulter station (Beckman
Coulter) and analyzed by the FloJo software. See the Supplemental
Experimental Procedures for cell enrichment and sorting procedure.
Cytokine Detection in Serum and Lung
Whole lung was ground in 1.8 ml 0.1% gelatin/PBS. Cytokine concentration
in the lungs and serum was analyzed by 22 plex multiplex ELISA (Millipore).
IFNb and IFNa were measured by ELISA (PBL Biomedicals).
Ex Vivo Infections and Serum Treatment
BM cells isolated from infected mice were incubated in RPMI containing
gentamycin,bmercaptoethanol, and2%normalmouseserumandwere infected
with SeV 52, influenzaPR8, orHSV atMOI of 2. Cellswere incubated for an addi-
tional 6hrprior tocollection forRNAextraction.Serumwas isolated from infected
mice at different times postinfection. Naive BM cells from WT or IFNRKO mice
were incubated in media containing freshly isolated serum for 6 hr at 37C.
Irradiation and BM Transplantation
Eight-week-old recipientmicewere lethallyg irradiatedwith1300 radsdelivered
in two doses of 650 rads each, 3 hr apart.Mice were injected intravenously with
2–33 106BMcells.Hematopoietic engraftmentwas analyzedbymeasurement
of blood chimerism 4 weeks after transplantation by flow cytometry. Experi-
ments were performed at least 8 weeks after transplant.
Adoptive Transfer and Isolation of Cells
Donor WT (n = 5) and IFNRKO (n = 5) CD45.1+ mice were infected for 4 days
with SeV. BM WT and IFNRKO cells were isolated and labeled with 3.5 mM
or 0.5 mM of CFSE, respectively. Donor WT and IFNRKO BM cells were evenly
mixed, and 107 cells were injected intravenously to recipient WT CD45.2+mice
infected with SeV for 2 days (n = 35). One day after the transfer,
CD45.1+CFSEhi/low cells were separated from the lung and spleen of recipient
mice by negative magnetic bead separation against CD45.2, followed by cell
sorting for high and low CFSE content. mRNA was extracted and amplified
by WT-Ovation RNA Amplification System (NuGEN, San Carlos CA) according
to the manufacturer’s instructions, prior to its analysis by qRT-PCR.
Statistical Analysis
We expressed the results as mean ± SD. We determined the statistical
significance of differences between two groups using one-sided Student’s
t tests. Values of at least p < 0.05 at a = 0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/j.
chom.2010.04.006.
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